The CRO and DTx specialist are joining forces to conduct a hybrid clinical trial of a potential digital therapeutic that is aimed at treating fibromyalgia.
The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.
This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.
The digital medicine solutions developer has received $300m in a Series D investment round, which will be used to help scale up its virtual care offerings.
The digital therapeutics specialist has announced the last patient has ended participation in a study investigating a precision solution for hypertension.
DCT company ObvioHealth helped digital therapeutic firm Renovia evaluate a way of helping women with incontinence issues strengthen pelvic floor muscles.
A leader from the VCRO shares how far the industry has come with decentralized adoption, where opportunities for improvement exist, and what lies ahead.
The pharmaceutical company and the digital therapeutics specialist are joining forces to help accelerate the expansion of various digital health solutions.
According to a representative from the decentralized trial solutions company, the field of digital therapeutics is poised to gain significant popularity.
Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.
The digital therapeutics firm's Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimer’s.
The decentralized trial tech firm will work with Applied VR on five studies testing the viability of virtual-reality therapy in treating pain patients.
An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.
The BiovitalsHF, from Biofourmis, is intended to augment decision-making in clinical environments, and to supplement traditional pharmaceutical therapies.
In the company’s latest partnership, TrialSpark has partnered with Limbix to design and implement a clinical trial for a digital therapeutic for adolescent depression.
